Table 2.
RRMS subjects, 120 timepoints, 1037 lesions, 9022 samples | ||||||
---|---|---|---|---|---|---|
χ2 = 5925; 5 | DF; p < 0.0001; R2 marginal |
= 0.45; R2 conditional = 0.67 |
||||
Effect | Prediction (nMU) |
Estimate (nMU) |
Std Error |
dDF | f | p |
Intercept (de novo lesions, baseline) |
0.45 | 0.45 | 0.053 | |||
Acute | −0.85 | −1.29 | 0.016 | 8072 | 4087 | <0.0001 |
Post-recovery | 0.13 | −0.31 | 0.014 | 7985 | 146 | <0.0001 |
Repeat lesions | −0.29 | −0.74 | 0.025 | 5171 | 865 | <0.0001 |
Repeat lesions: acute | −1.31 | 0.28 | 0.037 | 8119 | 20.6 | <0.0001 |
Repeat lesions: follow-up | −0.49 | 0.12 | 0.030 | 8789 | 3.34 | 0.068 |
SPMS subjects, 221 timepoints, 1283 lesions, 5548 samples | ||||||
---|---|---|---|---|---|---|
χ2 = 4794; 5 | DF; p < 0.0001; R2 marginal |
= 0.47; R2 conditional = 0.78 |
||||
Effect | Prediction (nMU) |
Estimate (nMU) |
Std Error |
dDF | f | p |
Intercept (de novo lesions, baseline) |
0.51 | 0.51 | 0.051 | |||
Acute | −0.99 | −1.51 | 0.025 | 4295 | 4485 | >0.0001 |
Post-recovery | −0.30 | −0.81 | 0.030 | 4410 | 700 | >0.0001 |
Repeat lesions | −0.74 | −1.25 | 0.029 | 5144 | 1612 | >0.0001 |
Repeat lesions: acute | −1.82 | 0.42 | 0.033 | 4323 | 20.4 | >0.0001 |
Repeat lesions: follow-up | −1.25 | 0.29 | 0.039 | 4655 | 5.70 | 0.017 |